MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea · Delayed Price · Currency is KRW 1,282.00
+10.00 (0.79%)
Jul 1, 2026, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Market Cap
MYUNGMOON Pharm co.,Ltd has a market cap or net worth of 42.52 billion as of June 30, 2026. Its market cap has decreased by -24.73% in one year.
Market Cap
42.52B
Enterprise Value
141.18B
Revenue
197.37B
Ranking
n/a
PE Ratio
14.07
Stock Price
1,282.00
Market Cap Chart
Since July 10, 2008, MYUNGMOON Pharm co.,Ltd's market cap has increased from 35.32B to 42.52B, an increase of 20.40%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 42.52B | -31.24% |
| Dec 30, 2025 | 61.84B | 1.70% |
| Dec 30, 2024 | 60.81B | -20.64% |
| Dec 28, 2023 | 76.62B | -21.03% |
| Dec 29, 2022 | 97.02B | -39.32% |
| Dec 30, 2021 | 159.90B | -34.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 118.22B |
| AptaBio Therapeutics | 112.37B |
| Jeil Pharma Holdings | 96.56B |
| HANDOK | 87.04B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 68.19B |
| Kukje Pharma | 64.65B |
| Ildong Holdings | 64.48B |